Note: Descriptions are shown in the official language in which they were submitted.
CA 02422289 2003-03-31
77774-12D
-1-
DIALYSATE COLLECTIO~P BAG AItD
1~T80D OF sTERZLIZING FLUID COLLECTED THEREIN
FIELD OF THE INVENTION
The present invention relates to the field of
medical dialysis including peritoneal dialysis and
hemodialysis. In particular, the present invention
relates to a dissolving bacteriocidal additive to a fluid
collection bag to sterilize the fluid collected in the
bag for safe disposal of the sterilized fluid.
~ACR~ROUND OF THE INVENTION
The common treatment f or renal failure is
hemodialysis treatment or peritoneal dialysis treatment.
Both treatments utilize the diffusion of liquid through a
semipermeable membrane. In the case of hemodialysis the
membrane is in a dialyzer external to the patient, so
that blood is withdrawn from the patient's vascular
system and passed across the membrane while dialysis
solution is passed across the other side of the membrane.
Impurities in the blood are drawn through the membrane by
osmotic pressure op the membrane and are disposed of in
the discarded dialysis solution. In the case of
peritoneal dialysis, the semipermeable membrane is the
patient's peritoneal membrane. Dialysis solution is
introduced into and retained for a period of time in the
peritoneal cavity, and impurities in the blood migrate
through the peritoneal membrane and into the dialysis
solution. The dialysis solution with the impurities is
then withdrawn from the peritoneal cavity and discarded
into a "drain" bag or "collection" bag.
Hoth hemodialysis and peritoneal dialysis
require significant amounts of dialysis solution,
CA 02422289 2003-03-31
77774-12D
-2-
sometimes called dialysate. Common dialysates are
primarily water, but With low ionic concentrations of
dissolved sodium, potassium, calcium, magnesium,
chloride, acetate, glucose and bicarbonate. The
proportions of these and other compounds depends on a
variety of factors. Regardless of the exact
concentrations and relative proportions of the dissolved
compounds, the main material in all dialysates is water.
Dialysis solutions have been premixed and
prepackaged in a variety of mixes and sizes, so that the
patient or the medical professional simply selects the
desired size and mix of dialysate, makes the appropriate
tubing connections to the prepackaged dialysates and to
the patient and the dialysis machine, and then commences
the procedure.
Regardless of the type of dialysis - peritoneal
dialysis or hemodiaiysis - the procedure results in
significant and sometimes substantial quantities of spent
dialysis solution. This used dialysis solution has been
exposed to and often contains a variety of pathogens
including infectious diseases. There are cases in which
used dialysis solution was found to contain viable HIv
virus, for example, and there are undoubtedly other
instances where used dialysis solution contained bacteria
or viruses of other diseases as well.
This used dialysis solution is normally deemed
"medical waste" and is required to be disposed of in
accordance with applicable medical waste disposal
procedures so as nat to spread disease or contaminate
water supplies. However, it is commonly recognized that
the used dialysis solution is often disposed of
improperly. Because many dialysis procedures are adapted
for the convenience of home use, used dialysis solution
is sometimes improperly discarded by simply putting it
into trash receptacles for ordinary trash pick-up or
CA 02422289 2003-03-31
77774-12D
-3-
pouring it into a sink or flushing it down the toilet.
Even in hospitals and clinics, the high cost and
inconvenience of medical waste disposal may tempt
professionals to dispose of used dialysis solution
improperly.
In the field of urinary catheters, there is a
body of art pertaining to preventing pathogens from
migrating from a urine collection bag up through a
catheter and into the urethra. Such art is not directed
toward the sterilization of the collected urine so that
it can be properly disposed of without infecting others
since urine does not normally contain infectious diseases
even if from a diseased patient. Instead, this art is
more directed toward preventing the collection bag from
becoming a colonization site from which infection can
migrate up the catheter to the patient himself.
Illustrative of this urinary catheter art are U.S. Patent
Nos. 4,529,398 by Wong; 4,661,100 by Rechsteiner;
5,267,989 by Moyet-Ortiz; 4,863,445 by Mayhan; 4,417,892
by Meisch; and 4,372,313 by Villari.
The typical approach to preventing urinary
tract infections in the urinary catheter prior art
mentioned above is to include a sterilizing agent in the
catheter or in the collection bag so that pathogens
cannot migrate up the catheter. Such an approach is not
appropriate for a dialysis collection bag, however,
because in dialysis it is often desired to take specimen
samples of the used dialysate. If the dialysate is
sterilized upon entering the collection bag, then
specimen samples cannot be cultured to test for live
pathogens. It is also desirable in dialysis that the
collection bag be entirely self-contained, so that the
collection bag is manufactured with the sterilizing agent
pre-placed within it to avoid a separate placement step
at the time. of use.
CA 02422289 2003-03-31
77774-12D ,
-4-
in the Wong patent, a dispensing device having
a.polymer with a chemoprophylactic agent is placed within
the collection bag. The dispensing device begins
sterilizing liquid in the collection bag immediately upon
coatact, and the device is designed such that the
sterilizing properties continue for an extended period of
time. In contrast, in dialysis collection bags it is
desirable that the sterilization of the liquid not be
commenced immediately upon contact with the dialysis
collection bag, and in dialysis collection bags it is not
necessary that the sterilization be contained for an
extended period of time because the bag is filled in a
very short period of time rather than over a period of
many hours.
The Rechsteiner patent discloses a system with
a urine collection bag having a fragile resinous materia l
inside which is broken to release a sterilizing or
diagnostic agent. The Rechsteiner patent is like the
Wong patent in that it is designed for urinary catheter
applications in which the collected urine must be
sterilized immediately upon contact and over an extended
period of time to prevent pathogen migration into the
patient. The Mayhan patent is similar to the Rechsteiner
patent, except that the resinous sterilizing agent is
replaced with a slow-dissolving tablet. The Moyet-Ortiz
patent discloses an antiseptic absorbent pad in a urine
collection device; the Meisch patent discloses an outlet
tube to a urine collection bag which is treated with a
sterilizing agent to prevent pathogen colonization; the
Villari patent discloses a urine collection bag with a
tubular portion having a device for retaining an
antimicrobial agent.
SUMMARY OF THE LNVENTION
The present invention includes a dialysis
CA 02422289 2006-06-19
60412-3418D
-5-
collection bag and method of using the same in dialysis
treatment and the disposal of used dialysis fluid. The
apparatus of the invention includes a used dialysate collection
bag having a strerilizing tablet within the collection bag.
The sterilizing pill is coated with a gelatinous coating to
delay the dissolution of the pill when the collection bag is
filled.
According to a broad aspect of the invention, there
is a peritoneal dialysis system, comprising: a dialysis tubing
set; a dialysis solution source; and a collection bag having a
sterilization bag attached by a frangible seal thereto, the
sterilization bag containing a sterilization agent therein for
sterilization of used dialysis solution in the collection bag.
In an alternative embodiment, the present
invention includes a used dialysate collection bag and a
sterilization bag connected thereto. The sterilization bag
contains a sterilizing agent and is attached to the
collection bag by a breakable connection. Once the
connection is broken, there is fluid communication between
the collection bag and the sterilization bag.
The system is operated by performing peritoneal
dialysis in the conventional manner, including the step of
draining the used dialysis solution into the collection bag.
In one embodiment, the used dialysis solution begins to
dissolve the gelatinous coating on the sterilization tablet
immediately upon entering the collection bag. However, the
gelatinous coating on the sterilization tablet is such that
the tablet does not release the sterilization agent for
about 30 minutes after the initial contact between the used
dialysis solution and the sterilization tablet. This 30 minute
delay allows time for a specimen sample to be taken from the
collection bag before the sterilization agent
CA 02422289 2003-03-31
77774-12D
-5a-
is released to sterilize the used dialysis solution. Once
the approximately 30 minutes expires so that the gelatinous
coating is dissolved and the sterilization agent is released
from the sterilization tablet, the sterilization agent is
completely released, substantially immediately. In an
alternative embodiment, when the sterilization agent is
contained in a sterilization bag attached to the collection
bag by a breakable connector,
CA 02422289 2003-03-31
77774-12D
_6_
once the collection bag hes been filled and samples taken
the connection between the two bags is broken and the
sterilization anent is completely released into the
dialysis solution. In either embodiment, unlike in the
case of urine collection bags used with urinary
catheters, there is no need for slow and prolonged
release over a period of time. The collection bag with
sterilized used dialysis solution is disposed of in the
standard proper manner as medical waste, but in the event
that the disposal is improper for some reason, there is
now much less likelihood of spreading infectious disease.
A variety of sterilization agents and
gelatinous coatings are feasible for the sterilization
tablet. In a preferred embodiment, the sterilization
agent is calcium hypochlorite and the coating is sodium
laurel sulfate,
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 shows a perspective view of a dialysis
collection bag in accordance with the present invention
FIG. 2 shows a perspective, partial cut-away
view of a sterilization tablet in accordance with the
present invention:
FIG. 3 shows a perspective view of an
alternative embodiment of the invention, showing a
sterilization bag attached to the dialysis collection bag
by a frangible seal.
DETAILED DESCRIPTION OF THE INVENTION
A perspective view of a dialysis collection bag
in accordance with the present invention is shown in FIG.
1. A dialysis collection bag 10 is a bag-shaped element
connected to a drain tube 12 which is connected to an
ordinary peritoneal dialysis or hemodialysis tubing set
(not shown). The collection bag 10 is sealed so that it
CA 02422289 2003-03-31
77774-12D
_7_
is liquid tight and liquid cannot enter or leave it
except through the drain tube 12. The collection bag 10
is constructed from plastic sheet material in the
conventional manner known in the art and is sized
appropriately so that the collection bag alone or in
combination with a collection bag set has sufficient
capacity to receive the used dialysis solution from a
dialysis treatment.
Inside the collection bag 10 is a sterilization
tablet 14. The sterilization tablet 14 is preferably
placed within the collection bag 10 at the time the
collection bag is being manufactured. The sterilization
tablet l4 is placed in the collection bag 10, and then
the collection bag 10 is sealed to retain the
sterilization tablet 14 therein. In a preferred
embodiment, the tablet contains calcium hypochlorite.
Other disinfectant agents are feasible as well, including
lithium hypochlorite, sodium hypochlorite, and powder
chloramines such as sodium p-toluene sulfonchloramide or
other soluble disinfectants. The quantity and
concentration of disinfectant should be sufficient to
quickly disinfect 2-4 liters of used dialysis solution
contained within the collection bag.
An important aspect of the preferred embodiment
of the invention is the use of a dissolving coating 16
over the body 18 of the sterilization tablet 14 as shown
in FIG. 2. The coating must be dissolved by contact with
the used dialysis solution before the disinfectant in the
sterilization tablet 14 is released. As explained above,
this delays the activation of the sterilization tablet 14
for a short time after initial contact with the used
dialysis solution, to allow time to take a specimen
sample before the disinfecting process commences. It has
been found that the most convenient time period to
provide between the initial contact between the
CA 02422289 2003-03-31
77774-12D
_g_
sterilization tablet 14 and the used dialysis solution,
to allow for the collection of a specimen sample, is
about 30 minutes.
The coating l6 in the preferred embodiment is
sodium laurel sulfate or gelatin. Other coatings are
also feasible to provide appropriate delay in activation
of the sterilization tablet 14, including ethylcellulose,
hydroxypropyl-methylcellulose, titanium dioxide, sucrose
stearate, hydroxypropylcellul.ose, polyvinyl-
acetaldiethylaminoacetate, or acrylic latex sprays. The
coating should dissolve in a pH range of 3-10.
The drain tube 12, as well as the rest of the
tubing set and the collection bag 10 as well, may be
sterilized at the time of manufacture by processes known
in the art. Such processes include but are not limited
to the use of ethylene oxide gas, steam, gamma rays and
electron beams.
The manufacturing method will normally include
the fabrication and assembly of the tubing set with its
various elements such as valves, clamps and so on; the
construction of the collection bag 10 with the
sterilization tablet 14 therein; the attachment of the
collection bag 10 to the drain tube 12; and the
sterilization of the entire assembly by one or more of
the known means mentioned above. The assembly is used in
peritoneal dialysis and hemodialysis procedures much like
tubing sets of the prior art. when the collection bag 10
is filled with used dialysis solution, the coating 16 to
the sterilization tablet 14 begins to dissolve. The time
it takes for the coating l6 to dissolve to the point
where the sterilization agent is released may vary, as
mentioned above, from a few seconds to an hour or longer.
Preferably; the time is at least a few minutes, in order
to allow time for a specimen sample to be taken, and the
time is not so long that the used dialysis solution may
CA 02422289 2003-03-31
77774-12D
_g_
be removed from the collection bag 10 prior to being
sterilized by release of the sterilization agent. It has
been found that about 30 minutes is ideal for this time
period.
Once any desired specimen sample has been
taken, and the coating 16 to the sterilization tablet 14
is dissolved so that the sterilization agent is released
from the sterilization tablet 14 to sterilize the used
dialysis solution, the collection bag 10 with the used,
sterilized dialysis solution therein is discarded. It is
still desirable that the collection bag 10 with the used,
sterilized dialysis solution therein be discarded as
medical waste, in accordance with proper medical waste
disposal procedures. However, the prior sterilization of
the used dialysis solution provides some assurance
against the spread of disease in the event that such
procedures are ignored or followed .improperly.
With reference now to FIG. 3, an alternative
embodiment of the present invention is readily
understood. In this embodiment, a sterilization bag 20
is attached to the collection bag 10 by a frangible
seal 22 which separates the bags. Preferably, the
sterilization agent will be placed with the sterilization
bag 20 when the sterilization bag and the collection bag
are being manufactured. As mentioned previously, the
quality and concentration of disinfectant contained
within the sterilization bag 20 should be sufficient to
quickly disinfect 2-4 liters if used dialysis solution
contained within the collection bag 10. A sealing device,
preferably of the heating type, will be employed to seal
the walls of frangible seal 22 so that the sterilization
agent is separate from the initially empty collection bag
10. The frangible seal 22 is readily deiaminated to
permit the free flow of materials between the containers
while securing the containers to each other.
CA 02422289 2003-03-31
~~~~4-iaD
-IO-
As described herein, peritoneal dialysis is
performed on a patient and the used dialysis solution is
collected in the collection bag 10. While the dialysis
solution is collected and the collection bag 10 is
filled, any desired specimen samples may be taken. Once
the desired specimen samples have been taken, the
frangible seal 22 between the collection bag 10 and the
sterilization bag 20 is broken, providing free flow of
materials between the compartments. The used dialysis
solution is sterilized substantially immediately. The
sterilization bag 20 and the collection bag 10 with the
used dialysis solution therein are discarded.
